Type of security: Stock
Sector: Health Care
Industry: Hospital/Nursing Management
Market Capitalization: 26.66 B
The data is delayed by 15 minutes.
Description: Fresenius Medical Care AG & Co. KGaA, a kidney dialysis company, provides renal dialysis products and services. It offers dialysis treatment, and related laboratory and diagnostic services through its network of 3,250 outpatient dialysis clinics in approximately 45 countries worldwide; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the U.S. for the hospitalized ESRD patients and for patients suffering from acute kidney failure. The company also provides pharmacy services, such as delivery and supply of renal medications to patients at homes or to dialysis clinics directly; vascular access surgery services; and manufactures and distributes products for the treatment of end-stage renal disease (ESRD). In addition, it offers laboratory services that include blood, urine, and other bodily fluid testing services; and hemodialysis (HD) m
|Shares Outstanding||610.73 M||EPS||EPS Growth - 4 Quarters||EPS Growth - Q/Q|
|EPS Growth - Y/Y||-20.08%||Sales Growth - 4 Quarters||Sales Growth - Q/Q||P/E|
|P/E To EPS Growth||P/S||P/BV||Price/Cash Per Share|
|Price/Free Cash Flow||28.67||ROA||ROE||ROI|
|Current Ratio||Quick Ratio||Long Term Debt/Equity||Debt Ratio|
|Gross Margin||Operating Margin||Net Profit Margin||Dividend Payout Ratio|
|Cash From Financing Activities||-237.29 M||Cash From Investing Activities||-208.84 M||Cash From Operating Activities||447.27 M||Gross Profit||1.18 B|
|Net Profit||209.55 M||Operating Profit||504.4 M||Total Assets||25.11 B||Total Current Assets||6.6 B|
|Total Current Liabilities||3.55 B||Total Debt||9.05 B||Total Liabilities||15.56 B||Total Revenue||3.96 B|
|High 52 week||56.81||Low 52 week||31.1||Last close||37.95||Last change||3.77%|
|RSI||81.85||Average true range||0.65||Beta||0.61||Volume||94.68 K|
|Simple moving average 20 days||7.47%||Simple moving average 50 days||6.84%||Simple moving average 200 days||-16.13%|
|Performance Week||5.98%||Performance Month||12.21%||Performance Quart||-4.12%||Performance Half||-24.08%|
|Performance Year||-29.48%||Performance Year-to-date||17.17%||Volatility daily||1.48%||Volatility weekly||3.31%|
|Volatility monthly||6.79%||Volatility yearly||23.51%||Relative Volume||258.11%||Average Volume||434.55 K|
|New High||New Low|
2019-06-06 02:00:21 | INSIGHT-Will Europe's clampdown on faulty medical devices hurt patients?
2019-06-02 09:09:00 | Is Cara Therapeutics a Buy Now?
2019-05-30 07:48:11 | Cara Shares Up on Positive Phase III Data for Itchiness Drug
2019-05-29 13:00:00 | Fresenius Medical Care Breaks Ground on Knoxville Distribution Center
2019-05-06 11:05:03 | Fresenius Medical FMS Q1 Earnings & Revenues Top Estimates
2019-05-02 15:24:26 | Edited Transcript of FME.DE earnings conference call or presentation 2-May-19 1:30pm GMT
2019-05-02 12:56:14 | Fresenius makes solid start to year after turbulent 2018
2019-04-02 13:19:22 | Fresenius Medical Care to pay $231M to resolve bribery charges
2019-03-30 12:56:15 | Hedge Funds Have Never Been This Bullish On Fresenius Medical Care AG FMS?
2019-03-29 12:53:47 | Fresenius Medical Care says U.S. settlement will not affect 2019, 2020 results
2019-03-29 12:43:00 | Fresenius Medical Care to pay $231 million to settle bribery charges
2019-03-26 11:48:03 | Fresenius Medical to Make Huge Investments, Competition Rife
2019-03-25 08:37:12 | Fresenius Medical's New Hemodialysis Software Gets FDA Nod
2019-03-19 10:41:02 | Baxter's BAX New Tie Up to Boost Acute Therapies Business
2019-03-15 13:40:37 | [$$] Fresenius Medical Care Readies for US Dialysis Shift
2019-03-14 10:05:02 | Should Value Investors Pick Fresenius Medical FMS Stock?
2019-03-11 09:49:30 | How Much Of Fresenius Medical Care AG & Co. KGaA ETR:FME Do Institutions Own?
2019-03-04 12:23:54 | U.S. seeks to cut dialysis costs with more home care versus clinics
2019-03-04 01:00:00 | FOCUS-U.S. seeks to cut dialysis costs with more home care versus clinics
2019-02-27 06:31:11 | Fresenius Medical FMS Earnings Beat, Revenues Miss in Q4
2019-02-26 07:00:00 | Fresenius Medical Care completes acquisition of NxStage Medical
2019-02-25 19:51:24 | [$$] German Dialysis Firm Reaches Agreement in Bribery Probe
2019-02-22 06:35:27 | FMC wraps up $2 bln acquisition of NxStage
2019-02-20 14:16:21 | Fresenius Medical Care AG & Co. FMS Q4 2018 Earnings Conference Call Transcript
2019-02-20 04:51:38 | FMC expects NxStage deal to close in next couple of days
2019-02-20 04:49:03 | Fresenius flags faster earnings growth from 2020 after investment
2019-02-20 04:38:47 | [$$] Fresenius Shares Rise on Strong Earnings
2019-02-20 01:24:24 | Fresenius Medical Care plans 1 bln eur share buyback
2019-02-19 08:35:44 | Should We Be Delighted With Fresenius Medical Care AG & Co. KGaA’s ETR:FME ROE Of 18%?
2019-01-31 16:09:56 | Better Buy: GW Pharmaceuticals vs. Cara Therapeutics
2019-01-30 08:31:48 | A Look At The Fair Value Of Fresenius Medical Care AG & Co. KGaA ETR:FME
2019-01-29 08:38:59 | FMC extends deadline for NxStage deal until Aug. 6 due to U.S. government shutdown
2019-01-24 14:56:46 | Becton, Dickinson Expected to Continue to Reward Shareholders
2019-01-22 07:08:00 | CytoSorbents Announces Expansion of CytoSorb® Partnership with Fresenius Medical Care
2019-01-16 08:14:01 | New Strong Sell Stocks for January 16th
2019-01-09 12:09:58 | Akorn Slides After Reporting FDA Warning Letter On Illinois Facility
2019-01-09 07:00:12 | New Strong Sell Stocks for January 9th
2019-01-08 07:21:12 | Baxter's PD Solution to Treat Patients, Prospects Bright
2019-01-03 17:43:10 | Cara CARA Up on IDMC's Recommendation to Continue Trial
2018-12-17 11:36:46 | Fresenius Medical Care AG & Co. FMS: Are Hedge Funds Right About This Stock?